On Friday shares of Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR-A) closed at $5.67. Zacks upgraded shares of Petroleo Brasileiro Petrobras SA (NYSE:PBR) from an underperform rating to a neutral rating in a report released on Wednesday. Zacks currently has $5.60 price objective on the stock.
ServiceMaster Global Holdings, Inc. (NYSE:SERV) in last trading activity fell -0.27% to close at $36.60. Company weekly performance is 2.52% while its quarterly performance stands at 35.01%. ServiceMaster Global Holdings, Inc. (NYSE:SERV) is -0.27% away from its 52 week high. On Mar 20 ServiceMaster Global Holdings, Inc. (NYSE:SERV) announced that it has filed a registration statement with the U.S. Securities and Exchange Commission relating to a proposed secondary offering of 20,000,000 shares of its common stock by certain stockholders of the Company, including investment funds sponsored by, or affiliated with, Clayton, Dubilier & Rice, LLC. In connection with the offering, the selling stockholders will grant the underwriters an option to purchase up to 3,000,000 additional shares of common stock.
On last trading day Synta Pharmaceuticals Corp. (NASDAQ:SNTA) advanced 2.90% to close at $2.48. Its volatility for the week is 5.52% while volatility for the month is 5.90%. SNTA’s EPS growth for past 5 years was -18.90%. Synta Pharmaceuticals Corp. (NASDAQ:SNTA) monthly performance is 3.77%. On March 12, Synta Pharmaceuticals Corp. (NASDAQ:SNTA) reported financial results for the fourth quarter and year ended December 31, 2014 and provided an operational update. There were no revenues recognized in the fourth quarters of 2014 and 2013. Research and development expenses were $15.7 million for the fourth quarter in 2014, compared to $20.0 million for the same period in 2013. Research and development expenses were $68.2 million for the year ended December 31, 2014, compared to $71.9 million for the same period in 2013.
Cleveland BioLabs, Inc. (NASDAQ:CBLI) has 0.30% insider ownership while its institutional ownership stands at 5.30%. In last trading activity company’s stock closed at $3.70. On Mar 16, Cleveland BioLabs, Inc. (NASDAQ:CBLI) announced that a maximally tolerated dose has been reached and that dosing has been completed in a Phase 1 healthy subject study of CBLB612, an investigational drug in development for mobilization of hematopoietic stem cells (HSCs) and for the prevention of chemotherapy-induced myelosuppression.
On last trading day Enservco Corporation (NYSEMKT:ENSV) fell -3.09% to close at $1.88. Its volatility for the week is 6.32% while volatility for the month is 6.37%. ENSV’s EPS growth for past 5 years was 34.50%. Enservco Corporation (NYSEMKT:ENSV) monthly performance is -17.54%. On March 28, ENSERVCO Corporation (NYSEMKT:ENSV), reported financial results for its fourth quarter and full year ended December 31, 2014. Revenue in the fourth quarter increased to a record $18.3 million, up 21% over $15.2 million in the same quarter last year. This $3.1 million increase is net of a $4.2 million decline in revenue year over year due to unseasonably warm temperatures until mid-November and lower propane revenues. Core well enhancement services — hot oiling, acidizing and frac water heating — increased 27% to a record $16.1 million from $12.6 million a year ago, more than offsetting a 17% decline in fluid management services — to $2.0 million from $2.4 million.